MAAT INDEX

CLAIM #48693 · Pfizer Inc (PFE) · 2025Q4 earnings call · Feb 3, 2026 · due Dec 31, 2026

This year, as Albert pointed out, we plan to start approximately 20 phase three programs driving the portfolio.

Chris Boshoff · Chief Scientific Officer

PENDING
graded after results covering Dec 31, 2026 are reported

How to check this claim

Look at: Number of new Phase 3 program starts initiated during fiscal year 2026

It came true if: Phase 3 program starts >= 18 (approximately 20)

Where: Company pipeline disclosures / management commentary (10-K, investor day, or quarterly earnings calls) for FY2026

Verify independently

SEC filings for PFE · Claim quote is verbatim from the 2025Q4 earnings call.